GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » FCF Yield %

Fusion Antibodies (LSE:FAB) FCF Yield % : -58.13 (As of May. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Fusion Antibodies's Trailing 12-Month Free Cash Flow is £-2.11 Mil, and Market Cap is £3.62 Mil. Therefore, Fusion Antibodies's FCF Yield % for today is -58.13%.

The historical rank and industry rank for Fusion Antibodies's FCF Yield % or its related term are showing as below:

LSE:FAB' s FCF Yield % Range Over the Past 10 Years
Min: -224.39   Med: -4.77   Max: -0.27
Current: -58.13


During the past 9 years, the highest FCF Yield % of Fusion Antibodies was -0.27%. The lowest was -224.39%. And the median was -4.77%.

LSE:FAB's FCF Yield % is ranked worse than
77.66% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs LSE:FAB: -58.13

Fusion Antibodies's FCF Margin % for the quarter that ended in Sep. 2023 was -249.72%.


Fusion Antibodies FCF Yield % Historical Data

The historical data trend for Fusion Antibodies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Antibodies FCF Yield % Chart

Fusion Antibodies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -39.37 -1.28 -3.73 -3.77 -18.65

Fusion Antibodies Semi-Annual Data
Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.21 1.38 -16.76 -15.10 -82.63

Competitive Comparison of Fusion Antibodies's FCF Yield %

For the Biotechnology subindustry, Fusion Antibodies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fusion Antibodies's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's FCF Yield % falls into.



Fusion Antibodies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Fusion Antibodies's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.868 / 10.0157365
=-18.65%

Fusion Antibodies's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.351 * 2 / 3.2699535
=-82.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fusion Antibodies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Fusion Antibodies FCF Yield % Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fusion Antibodies (LSE:FAB) Business Description

Traded in Other Exchanges
N/A
Address
1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL
Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Fusion Antibodies (LSE:FAB) Headlines

From GuruFocus

626 Financial, LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-21-2022